According to FutureWise analysis, the market for cardiovascular genetic testing in 2023 is US$10.84 billion, and is expected to reach US$26.12 billion by 2031 at a CAGR of 11.6%. The cardiovascular genetic testing market is experiencing significant growth, driven by the ongoing expansion and modernization of healthcare infrastructure, as well as the increasing prevalence of chronic diseases...